<Record>
<Term>Antifibrinolytic Agents</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Fibrin Modulating Agents</ParentTerm>
<ParentTerm>Hemostatics</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/Fibrin Modulating Agents/Antifibrinolytic Agents</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Hematologic Agents/Coagulants/Hemostatics/Antifibrinolytic Agents</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Coagulants</BroaderTerm>
<BroaderTerm>Hematologic Agents</BroaderTerm>
<BroaderTerm>Fibrin Modulating Agents</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Hemostatics</BroaderTerm>
<BroaderTerm>Antifibrinolytic Agents</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<Synonym>Antiplasmins</Synonym>
<Synonym>Antifibrinolysins</Synonym>
<Synonym>Antifibrinolytic Agents</Synonym>
<Synonym>Antifibrinolytics</Synonym>
<Synonym>Plasmin Inhibitor</Synonym>
<Synonym>Plasmin Inhibitors</Synonym>
<Description>Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.</Description>
<Source>MeSH</Source>
</Record>
